UMIN ID: UMIN000002222
Registered date:21/07/2009
Phase II clinical trial of interleukin-2, interferon-alpha and tegafur uracil therapy for advanced renal cell cancer
Basic Information
| Recruitment status | Complete: follow-up complete |
|---|---|
| Health condition(s) or Problem(s) studied | advanced renal cell cancer |
| Date of first enrollment | 2009/07/01 |
| Target sample size | 50 |
| Countries of recruitment | Japan |
| Study type | Interventional |
| Intervention(s) | Interleulin-2, inteferon-alpha, tegafur uracil |
Outcome(s)
| Primary Outcome | anti-tumor response |
|---|---|
| Secondary Outcome | Time to progression, duration of response, overall survival, servival at home, performance status |
Key inclusion & exclusion criteria
| Age minimum | 20years-old |
|---|---|
| Age maximum | 75years-old |
| Gender | Male and Female |
| Include criteria | |
| Exclude criteria | (1)uncontrolled DM (2)ischemic heart disease (3)allergic reaction to IL-2 and/or IFN-alpha (4)auto-immune disease (5)patients having Shou-Sai-Kotou (special herbal drug) and/or steroids (6)depression (7)Investigator determines as unsuitable |
Related Information
| Primary Sponsor | Department of Urology Faculty of Medicine |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | None |
| Secondary ID(s) |
Contact
| public contact | |
| Name | Yoshihiko Tomita |
| Address | Iida-nishi 2-2-2 Yamagata Japan |
| Telephone | 023-628-5368 |
| ytomita@med.id.yamagata-u.ac.jp | |
| Affiliation | Yamagata University Hospital Department of Urology |
| scientific contact | |
| Name | Yoshihiko Tomita |
| Address | Iida-nishi 2-2-2 Yamagata Japan |
| Telephone | 023-628-5368 |
| ytomita@med.id.yamagata-u.ac.jp | |
| Affiliation | Yamagata University Department of Urology Faculty of Medicine |